建議您使用以下瀏覽器觀看合一網站，
以獲得最佳瀏覽效果。
如何使用IE找到Microsoft Edge?
-
開啟新分頁(紅色框)
-
於搜尋框中打入Edge(紅色框)，並按搜尋(藍色框)
-
點擊【立即啟動】(藍框處)打開 Microsoft Edge
Title
Oneness Biotech Co., Ltd. receives an United Arab Emirates patent titled "TOPICAL FORMULATION FOR PROMOTING WOUND HEALING" on Fespixon cream (Research code: ON101).
The Company's 2025Q1 consolidated financial statements have been approved by the Board of Directors
The medical device registration application of Bonvadis for all indications in wounds has been accepted by India CDSCO.
News-Outstanding Corporate Governance Evaluation Results for the Microbio Group Microbio and Oneness Rank among Top 5% in the Corporate Governance Evaluation for Four Consecutive years; Diamond Biofund Enters Top 5% on Its First Evaluation
The medical device registration application of Bonvadis for all indications in wounds has been accepted by Egypt EDA.
Oneness announces information about the first investor conference in 2025.
The medical device registration application of Bonvadis for all indications of wounds has been accepted by Australia TGA
Oneness has submitted 510(k) application of Bonvadis for full thickness wound indications to the U.S. FDA
Announcement for the Board of Directors' resolution to dispose of (sublease) part of a right-of-use assets to a related party.
Announcement for the Board of Directors' resolution to acquire part of a right-of-use assets to a related party.
The medical device registration application of Bonvadis for all indications of wounds has been accepted by Brazil ANVISA.
Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis from Brazil ANVISA.
The medical device registration application of Bonvadis for all indications in wounds has been accepted by UAE MOHAP
Oneness Board of Directors resolved to convene the Annual Shareholders' Meeting of 2025.
The Board of Directors resolved not to distribute dividends.
建議您使用以下瀏覽器觀看合一網站，
以獲得最佳瀏覽效果。
如何使用IE找到Microsoft Edge?